Format

Send to

Choose Destination
See comment in PubMed Commons below
Blood. 2004 Jul 15;104(2):572-8. Epub 2004 Mar 25.

Bone marrow transplantation restores immune system function and prevents lymphoma in Atm-deficient mice.

Author information

  • 1Transplantation Biology Research Center, Massachusetts General Hospital, MGH-East, 149-5210 13th St, Boston, MA 02129, USA.

Abstract

Ataxia-telangiectasia (A-T) is a human autosomal recessive disease caused by mutations in the gene encoding ataxia-telangiectasia mutated (ATM). A-T is characterized by progressive cerebellar degeneration, variable immunodeficiency, and a high incidence of leukemia and lymphoma. Recurrent sino-pulmonary infections secondary to immunodeficiency and hematopoietic malignancies are major causes of morbidity and mortality in A-T patients. In mice, an introduced mutation in Atm leads to a phenotype that recapitulates many of the symptoms of A-T, including immune system abnormalities and susceptibility to malignancy. Here we show that the replacement of the bone marrow compartment in Atm knockout mice (Atm(-/-)) using a clinically relevant, nonmyeloablative host-conditioning regimen can be used to overcome the immune deficiencies and prevent the malignancies observed in these mice. Therefore, bone marrow transplantation may prove to be of therapeutic benefit in A-T patients.

PMID:
15044255
DOI:
10.1182/blood-2003-12-4226
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center